New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Increased risk for suicide may be associated with head injuries, highlighting the connection between head trauma and ...

Long-term research indicates that anorexia nervosa onset in adolescence predicts higher psychiatric outpatient care and medication use.

Widespread misinterpretation of instructions for patients on a health questionnaire highlights the need for more clear patient communication.

FDA grants Priority Review to AXS-05 (dextromethorphan/bupropion) for the treatment of agitation associated with Alzheimer disease.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

Among pregnant individuals, the rate of opioid-related diagnoses has increased and appears to be associated with increased risk for morbidity.

Pharmacist-directed medical cannabis programs may serve as a replacement for prescription opioids in chronic pain management.

Circadian rhythms that are weaker, more fragmented, or easily disrupted may be associated with increased risk for dementia.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Short-term treatment with cannabinoid products that have a comparable or high THC-to-CBD ratios may improve pain outcomes.

Over the past 2 decades, the prescription of certain controlled medications has decreased in adolescent and young adult populations.